Chemical and pharmacological investigations of Epimedium species: a survey.

More than 130 different compounds have been identified from over 16 species of the Epimedium genus of the Berberidaceae family. Eight of these species have been used in the Traditional Chinese Medicines (TCM) over centuries to treate a wide range of diseases. From in vitro and in vivo experimental data, and preliminary structure-activity relationship (SAR) analysis of the androgenic/anti-estrogenic and anti-oxidant activities of the icariin series of flavonoids and glycosides, the results appear to be consistent with those of known anti-estrogenic flavonoids, such as luteolin. Further QSAR analysis of the different active ingredients is now in progress and will be reported elsewhere. Our survey suggests the possibility of multiple targets and multiple mechanisms of action by Epimedium preparations and their purified compounds. These may serve as leads for further new drug development.

[1]  T. Takemoto,et al.  [Studies on the constituents of Epimedium. III. Lignoids of Epimedium grandiflorum Morr. (author's transl)]. , 1975, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[2]  Ying-jie Chen,et al.  Studies on the Constituents of Epimedium koreanum. III , 1995 .

[3]  S. Sung,et al.  Antihepatotoxic Activity of Icariin, a Major Constituent of Epimedium koreanum , 1995, Planta medica.

[4]  K. Sin,et al.  [New Prenylflavonoid Glycosides from Epimedium koreanum]. , 1990, Planta medica.

[5]  Yu-lin Huang,et al.  Three new 2-phenoxychromones from the leaves of Epimedium sagittatum , 1993 .

[6]  Yuka Ishida,et al.  Flavonol glycosides in the roots of Epimedium diphyllum , 1989 .

[7]  M. Iinuma,et al.  Sutchuenoside A : a new Kaempferol glycoside from the aerial parts of Epidemium sutchuenense , 1991 .

[8]  K. Chiba,et al.  Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells. , 2000, Planta medica.

[9]  T. Fukai,et al.  Seven prenylated flavonol glycosides from two Epimedium species , 1988 .

[10]  H. Bui,et al.  Quantitative structure-activity relationship analysis of phenolic antioxidants. , 1999, Free radical biology & medicine.

[11]  T. Miyase,et al.  Ionone and lignan glycosides from Epimedium diphyllum , 1989 .

[12]  Kee Chang Huang,et al.  The Pharmacology of Chinese Herbs , 1998 .

[13]  T. Miyase,et al.  Studies on the Glycosides of Epimedium grandiflorum MORR. Var. thunbergianum (MIQ.) NAKAI. I , 1987 .

[14]  T. Miyase,et al.  Lignan and terpene glycosides from Epimedium sagittatum , 1991 .

[15]  S. Sung,et al.  Anti-hepatotoxic activity of icariside II, a constituent ofEpimedium koreanum , 1995 .

[16]  P. Xiao,et al.  Flavonoids from Epimedium wanshanense. , 1996, Phytochemistry.

[17]  Y. L. Liu,et al.  New tetrasaccharide flavonol glycoside from Epimedium acuminatum. , 1992, Journal of natural products.

[18]  P. Xiao,et al.  A 9,10-dihydrophenanthrene derivate from Epimedium koreanum , 1995 .

[19]  J. Wang,et al.  [Effect of epimedium sagittatum on soluble IL-2 receptor and IL-6 levels in patients undergoing hemodialysis]. , 1995, Zhonghua nei ke za zhi.

[20]  R. Hiltunen,et al.  Isolation and Immunomodulating Effect of Flavonol Glycosides from Epimedium hunanense , 1997, Planta medica.

[21]  常松 竹本,et al.  Epimedium属植物の成分研究(第5報)イカリソウのフラボノイド その4 , 1975 .

[22]  Linda Raber,et al.  BLUEPRINT FOR R&D SPENDING , 1997 .

[23]  V. Kolb.  Herbal medicine of Wisconsin Indians. , 2002, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[24]  L. Geng,et al.  Immunopharmacology and toxicology of the plant flavonoid baohuoside-1 in mice. , 1994, International journal of immunopharmacology.

[25]  Liu Yl,et al.  Acuminatin from the aerial part of Epimedium acuminatum , 1992 .

[26]  P. Xiao,et al.  A difuranoflavone from Epimedium koreanum , 1995 .

[27]  宮瀬 敏男,et al.  Studies on the Glycosides of Epimedium grandiflorum MORR. var. thunbergianum (MIQ.) NAKAI. III , 1988 .

[28]  S. Shi,et al.  [Effects of Epimedium sagittatum on immunopathology and extracellular matrices in rats with chronic renal insufficiency]. , 1994, Zhonghua nei ke za zhi.

[29]  F. Li,et al.  [Studies on the isolation and structures of baohuoside-II, III, IV and V]. , 1988, Yao xue xue bao = Acta pharmaceutica Sinica.

[30]  C. C. Chen,et al.  New prenylflavones from the leaves of Epimedium saggitatum. , 1996, Journal of natural products.

[31]  T. Miyase,et al.  Ionone and bibenzyl glycosides from Epimedium grandiflorum var. Thunbergianum , 1991 .

[32]  M. Iinuma,et al.  A Flavonol Glycoside from Epimedium diphyllum , 1990 .

[33]  K. Andersson,et al.  Regulation of tone in penile cavernous smooth muscle , 1994, World Journal of Urology.

[34]  I. Morita,et al.  Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication. , 2000, Planta medica.

[35]  Y. Oshima,et al.  Epimedins A, B and C, flavonoid glycosides of Epimedium koreanum herbs , 1987 .

[36]  P. Xiao,et al.  Flavonol glycosides from Epimedium koreanum. , 1995, Phytochemistry.

[37]  S. Kang,et al.  Flavonoids from Epimedium koreanum , 1991 .

[38]  Z. Darżynkiewicz,et al.  Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies. , 2002, International journal of oncology.